Reletter
Artwork for mejbcart’s Newsletter

mejbcart’s Newsletter

mejbcart

Sars-CoV-2 Spike bioinformatics and related issues

Platform
Substack
PricingOnly free issuesPublishesWeekly
Issues61SubscribersRead mejbcart.substack.com

Curious about how many subscribers mejbcart’s Newsletter has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over one million newsletters.

Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.

Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.

Contact Information
How Many Subscribers?
Reletter gives you subscriber numbers, contacts, chart rankings, traffic estimates and more across 1.6m+ newsletters.

Latest Issues

Recent posts by this newsletter. Browse the email archive.

Stanford, Penn, MIT et al. dream, genetically modified world. More Spike2020 companions, with ADAM33, no EVE yet...

Imagine, all the sepsis cases could have been prevented by applying a super fast, huge dose of intravenous Vitamin C^18 and few other essential nutrients!!!

a month ago
15
6

The white clots after the genetically modifying covid injections. Is it the -KV- to -PP- mutation, Fibrin/-ogen, or all of it?

Update 3/2/2024: Heavy metal detox (including calcification being part of the clots ) presented in https://go2.thetruthaboutcancer.com/eastern-medicine/episode-3/ patent US6720356B2 with more details at the end of the post

2 months ago
15
9

Covid19 and what alpha-lipoic acid (ALA) can do for You?

Update 2/21/2024: Substack is blocking sending of the comments on this post. So, dear readers, please have patience with responses to something I can’t get/see….

2 months ago
14
34

What does the X possibly stand for? Will Bill Gates et al. succeed?

The main post is behind the divider bar, first some updates:

3 months ago
16
27

Authors

The writers behind this newsletter.

  • mejbcart

    macromolecular crystallographer, biophysicist, PhD

  • Frequently Asked Questions

    How can I access the email archive for mejbcart’s Newsletter?

    You can find recent issues that have been published by mejbcart’s Newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.

    How many subscribers does mejbcart’s Newsletter have?

    To see how many people subscribe to mejbcart’s Newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.

    How can I advertise in mejbcart’s Newsletter?

    Newsletter advertising can be extremely effective when it's done right. Before you pitch mejbcart’s Newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.

    Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.

    How much does it cost to sponsor a publication like mejbcart’s Newsletter?

    Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.

    To find out how much an ad will cost, contact mejbcart’s Newsletter using the contact information provided and ask for a copy of their media kit.

    How can I find newsletters similar to mejbcart’s Newsletter?

    Scroll up to where it says Similar Newsletters to see other publications like mejbcart’s Newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.

    How do I contact mejbcart’s Newsletter?

    Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.